北京商报讯（记者 董晗萱）中小微企业贷款也有真金白银支持！1月20日，财政部等部门连发多条通知，在优化个人消费贷款、经营贷贴息政策的同时，明 确实施中小微企业贷款贴息政策。 政策要求，对2026年1月1日起经办银行发放的、符合条件的中小微民营企业固定资产贷款和中小微民营企业参与项目使用的新型政策性金融工具资金，中央 财政按照贷款本金给予年化1.5个百分点、期限不超过2年的贴息支持，单户贴息贷款规模上限5000万元。政策实施期限暂定1年，后续可视情况延长。 适用对象为，投向相关重点领域产业链及其上下游产业的全部中小微民营企业（包括但不限于由支持小微企业融资协调工作机制推荐或由工业和信息化部共 享的优质中小微民营企业）固定资产贷款，中小微民营企业参与项目使用的新型政策性金融工具资金。 投向领域包括，支持新能源汽车、工业母机、医药工业、医疗装备、基础软件和工业软件、民用大飞机、服务器、移动通信设备、新型显示、仪器仪表、工 业机器人、轨道交通装备、船舶与海洋工程装备、农机装备等相关重点产业链及上下游产业，科技服务、物流服务、信息和软件服务、节能环保服务、生产 性租赁服务、商务服务等生产性服务业领域，农、林、牧、渔、农 ...

据新华社消息，1月20日，财政部、国家发展改革委、工业和信息化部、中国人民银行、金融监管总局等 5部门对外发布通知， 明确实施中小微企业贷款贴息政策 。 政策支持范围为2026年1月1日起经办银行发放的、符合条件的中小微民营企业固定资产贷款和中小微企业参与 项目使用的新型政策性金融工具资金，支持领域包括重点产业链及上下游产业、生产性服务业等。 据介绍， 贴息方案为每年贴息1.5个百分点 ，最长贴息2年，单户贴息贷款规模上限5000万元，单户最多可享 受贴息150万元。政策实施期暂定1年，后续可视情延长。 具体来说，投向领域为支持新能源汽车、工业母机、医药工业、医疗装备、基础软件和工业软件、民用大飞 机、服务器、移动通信设备、新型显示、仪器仪表、工业机器人、轨道交通装备、船舶与海洋工程装备、农机 装备等相关重点产业链及上下游产业，科技服务、物流服务、信息和软件服务、节能环保服务、生产性租赁服 务、商务服务等生产性服务业领域，农、林、牧、渔、农副产品加工业领域，以人工智能等为代表的新兴领 域。 通知还表示，财政部会同金融监管总局酌情组织财政部各地监管局、金融监管总局各监管局开展联合抽查， 发现被贴息企业有严重违规 ...

Investment Rating - The report maintains a "Recommended" rating for the medical device sector, particularly highlighting opportunities in innovative drugs and medical devices [49]. Core Insights - The report emphasizes a transition in the innovative drug sector from quantity to quality, suggesting a focus on differentiated products and internationalization by 2025 [11]. - In the medical device sector, there is a notable recovery in bidding volumes for imaging equipment, with a focus on companies like Mindray and United Imaging [11]. - The report identifies a significant growth potential in the orthopedic market due to aging demographics and increasing surgical penetration rates in China [43]. - The life sciences service sector is experiencing a demand recovery, driven by both domestic and international market needs, with a focus on the importance of mergers and acquisitions for growth [50]. Summary by Sections Market Review - The medical index rose by 7.70%, outperforming the CSI 300 index by 4.91 percentage points, ranking 5th among 30 sectors [7]. - The top-performing stocks included Baitai, Innovation Medical, and Sanbo Neuroscience, while the worst performers were Baihua Pharmaceutical and Jinhao Medical [7]. Overall Views and Investment Themes - Innovative drugs are expected to see a shift towards quality, with a focus on companies like BeiGene and Innovent [11]. - Medical devices are benefiting from a recovery in bidding for imaging equipment and a push for domestic substitutes in the market [11]. - The innovative chain (CXO + life sciences services) is anticipated to see a rebound in investment, with a focus on high-growth potential companies [11]. - The report highlights the potential for growth in the blood products sector, with an emphasis on companies like TianTan Biological and Boya Biological [11]. Specific Company Insights - Neuralink is positioned as a leader in the invasive brain-computer interface sector, with significant advancements in its technology and clinical trials [21]. - Synchron is noted for its endovascular brain-computer interface, which offers a safer solution for severely paralyzed patients [25]. - Paradromics focuses on high-bandwidth brain-computer interfaces, aiming to decode complex human intentions [32]. - CorTec is pioneering closed-loop brain-computer interfaces, providing real-time interaction between the brain and external devices [36]. - Precision Neuroscience is innovating minimally invasive implantation techniques for brain-computer interfaces [39]. - Blackrock Neurotech is recognized for its comprehensive solutions in the brain-computer interface field, aiding patients with sensory restoration and control [42].